TrademarkDir
PERSPECTIVES IN ONCOLOGY
DEAD

Serial Number

73615808

Owner

Dominus Publishing Company, Inc.

First Use Date

Jul 17, 1986

Filing Date

Aug 21, 1986

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

PERSPECTIVES IN ONCOLOGY Trademark

Serial Number: 73615808 • Registration: 1437281

PERSPECTIVES IN ONCOLOGY is a trademark filed by Dominus Publishing Company, Inc. on August 21, 1986. The trademark is classified under Class 16 (Paper Goods). The application is currently no longer active.

Owner Contact Info

Dominus Publishing Company, Inc. (4 trademarks)

Roslyn, NY 11576

Entity Type: 03

Trademark Details

Filing Date

August 21, 1986

Registration Date

April 21, 1987

First Use Anywhere

July 17, 1986

First Use in Commerce

July 17, 1986

Published for Opposition

January 27, 1987

Cancellation Date

January 21, 1998

Filing History

CANCELLED SEC. 8 (6-YR)
Jan 21, 1998 C8..
CANCELLED SEC. 8 (6-YR)
Jan 21, 1998 C8..
RESPONSE RECEIVED TO POST REG. ACTION
Jan 13, 1994 RRPR
RESPONSE RECEIVED TO POST REG. ACTION
Jan 13, 1994 RRPR
POST REGISTRATION ACTION MAILED - SEC. 8
Dec 16, 1993 PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
Dec 16, 1993 PRA8
REGISTERED - SEC. 8 (6-YR) FILED
Mar 25, 1993 8.AF
REGISTERED - SEC. 8 (6-YR) FILED
Mar 25, 1993 8.AF
REGISTERED-PRINCIPAL REGISTER
Apr 21, 1987 R.PR
REGISTERED-PRINCIPAL REGISTER
Apr 21, 1987 R.PR
PUBLISHED FOR OPPOSITION
Jan 27, 1987 PUBO
PUBLISHED FOR OPPOSITION
Jan 27, 1987 PUBO
NOTICE OF PUBLICATION
Dec 22, 1986 NPUB
NOTICE OF PUBLICATION
Dec 22, 1986 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 4, 1986 CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 4, 1986 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 14, 1986 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 14, 1986 CRFA
NON-FINAL ACTION MAILED
Oct 30, 1986 CNRT
NON-FINAL ACTION MAILED
Oct 30, 1986 CNRT
ASSIGNED TO EXAMINER
Oct 22, 1986 DOCK
ASSIGNED TO EXAMINER
Oct 22, 1986 DOCK

Related Trademarks

More from this Owner

ONCOLOGY

ONCOLOGY

ONCOLOGY

ONCOLOGY

ONCOLOGY

ONCOLOGY

CANCERNEWS

CANCERNEWS

CANCERNEWS

CANCERNEWS